About this event

  • Date and time Thu 28 Jan 2021 from 4:30pm to 5:30pm
  • Location Online
  • Organised by Endocrinology and Diabetes

This 3-part webinar series will explore the challenges in managing heart failure and renal disease in diabetes. It will promote understanding and communication between general practitioners, cardiologists, nephrologists and endocrinologists working together to combat heart failure and diabetes.

In this final webinar, specialists unite to discuss adopting a multifactorial approach for therapeutics and whether cardiologists and nephrologists should be able to prescribe sodium glucose transporter-2 inhibitors (SGLT2i).

During this webinar you will:

  • Learn whether non-diabetologists should administer SGLT2i
  • Acknowledge new changes in therapeutics 
  • Understand the benefits of a multifactorial approach in dealing with diabetes

Have you registered for part 1 and 2 yet? Sign up to them now and get part 3 for free. Please email events@rsm.ac.uk to claim your free place:

A certificate of attendance and CPD certificate with 1 CPD credit(s) per webinar of this series will be issued to those joining the webinars live. Certificates of attendance for CPD will be automatically issued after 7 days, but only where a delegate watches the webinar live in its entirety. 

10 x bursary places are available for this series. Please email endocrinology@rsm.ac.uk to claim your place.

Join in the conversation online
Follow us on Twitter: @RoySocMed 

We would like to thank our sponsors Eli Lilly and Company for their support of this webinar. Please note that the scientific programme and content has not been influenced in any way by the sponsors.

Key speakers

Professor Miles Fisher

Honorary Professor, University of Glasgow

Speaker's biography


Miles Fisher is a consultant diabetologist from Glasgow and an Honorary Professor at the University of Glasgow. Professor Fisher gained his medical degree from the University of Glasgow, UK and completed training in diabetes and endocrinology in the West of Scotland. Professor Fisher’s research interests are in cardiovascular aspects of diabetes, the pathophysiology of hypoglycaemia, and new treatments for diabetes. He received his MD in 1988 for his thesis on ‘Evidence for a diabetic cardiopathy.’ He was on the steering committee of the DIGAMI 2 study and was the Scottish co-ordinator. He was an events adjudicator for the HOPE, HOPE-2 and HOPE-TOO cardiovascular outcome trials, and for the albiglutide Harmony phase 3 development programme. He is currently a member of the Team Novo Nordisk Research Consortium studying professional cyclists with type 1 diabetes .He has been involved in guideline development for the Scottish Intercollegiate Guidelines Network (SIGN) and the European Society of Cardiology (ESC) and in guideline reviewing for SIGN, ESC, European Association for the Study of Diabetes (EASD) and NICE. He is the editor or co-editor of four books on heart disease in diabetes, three books on hypoglycaemia, and a book on SGLT2 inhibitors. He is the author or co-author of 49 book chapters, 84 original papers, 75 review articles, 36 leaders and editorials, 54 drug notes for Practical Diabetes and 15 drug notes for the British Journal of Cardiology.

Professor Juris Meier

Professor of Medicine, Chief Physician, Diabetes Centre Bochum Hattingen


View the programme

Welcome and introduction

Dr Ketan Dhatariya, Consultant in Diabetes and Endocrinology and Honorary Professor of Medicine, Norfolk and Norwich University Hospitals NHS Foundation Trust and Dr Abdul Lakhdar, Consultant Endocrinologist, Barts Health NHS Trust

Should cardiologists and nephrologists prescribe SGLT2i?

Professor Miles Fisher, Honorary Professor, University of Glasgow

Cardiovascular effects of GLP-1 RAs

Professor Juris Meier, Professor of Medicine, Chief Physician, Diabetes Centre Bochum Hattingen

Panel discussion
Close of meeting




More from this series:

EDP50 Promo
Webinar CPD

Kidneys, heart and diabetes: Science and practice – Part 1

This 3-part webinar will explore the challenges in managing heart failure and renal disease in diabetes.

In this first webinar, experts in their field unite to address recent clinical trial results for the management of thrombosis in diabetes and discuss new practises in the management of heart failure.

EDP50 Promo
Webinar CPD

Kidneys, heart and diabetes: Science and practice – Part 2

This 3-part webinar series will explore the challenges in managing heart failure and renal disease in diabetes. 

In this second webinar, join us to understand the newest inhibitors and receptor agonists in the treatment of diabetes put in place for cardio-renal protection.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted. 

Webinar recordings will be available for registered delegates up to 30 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place. 

This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.  

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member